• 图文组件
  • 图文组件
  • 图文组件

  风湿消息

亮相 2024 APLAR | 北京大学人民医院风湿免疫团队4项大会发言、2个特邀报告、31个壁报亮相 2024 APLAR

2024年8月21日至25日,备受瞩目的第26届亚太风湿病联盟年会(APLAR 2024)在新加坡隆重举行。共计2000余名来自世界各地的从事风湿病学、免疫学以及相关领域的专家学者齐聚Suntec会议中心,共同探讨全球风湿免疫领域的最新研究和进展。

开幕式典礼(视频)
本次大会的主题为:跨越国家,推动进步,旨在加强亚太地区风湿病学领域的交流与合作,会议收到1435篇摘要,邀请了来自29个国家的专家学者,共同探讨风湿免疫领域的前沿话题。大会设置了44个专场,140位演讲嘉宾,涉及类风湿关节炎、系统性红斑狼疮、干燥综合征、风湿病超声、自身炎症性疾病等讨论专场,并有风湿免疫领域前沿项目的壁报展示,为与会者分享了丰富的学术资源和最新的研究进展。
此次会议上,北京大学人民医院风湿免疫科参会代表共19人参加了会议,在大会进行了4项大会发言、其中2个特邀报告、31个壁报展示。
栗占国教授受邀在开幕式发言,何菁教授和孙晓麟教授分别做了特邀报告,孙兴和韩奕芃分别做了大会发言,内容包括非TCR偶联变构肽在RA中的应用、抗SSA/SSB阴性的干燥综合征患者中Th细胞谱特征、JAKi治疗难治性大动脉炎、B细胞亚群和炎性肌病等,获得了与会者的关注和好评。

北京大学人民医院参会代表合影,新加坡

此外,该团队再次被批准为亚太风湿病中心(COE),成为亚太地区连续获得授牌的三个中心之一,将作为亚太风湿病研究和交流中心,承担亚太地区风湿病青年医生的培训等任务。

APLAR 2024为全球风湿免疫学领域的专家学者提供了交流合作的平台,众家云集,各抒己见。秉持科学研究与临床应用相结合的理念,致力于推动风湿免疫学理论与治疗的创新发展,将前沿的学术成果尽快转化到临床治疗中,更好的为风湿免疫患者解除病痛。

闭幕式典礼(视频)

2025年APLAR年会将在日本福冈召开,让我们相约明年再相聚!
附:投稿录用情况

姓名

投稿题目

李英妮

Reliable detection of IL-2 in CD3+ T cells to assess
disease status and treatment suitability in systemic lupus erythematosus patients

李嘉辰

Baricitinib for Takayasu arteritis refractory to TNF-α inhibitors: a prospective pilot open-label study

金善钊

Single-Cell Profiling Changes Associated with Drug Resistance and Disease Progression to Methotrexate and Anti-TNF Therapies in RheumatoiSingle-Cell Profiling Changes Associated  with Drug Resistance and Disease Progression to Methotrexate and Anti-TNF Therapies in Rheumatoid Arthritisd Arthritis

曾星月,

李雪

Systemic lupus erythematosus presenting solely as hemolytic anemia: a distinct subgroup characterized by unique mechanisms, disease severity, and prognosis

徐丽玲

The role of growth arrest specific protein 6 in antiphospholipid syndrome

王乃迪

Analysis
of real-world efficacy of low-dose interleukin-2 in rheumatoid arthritis and
predictors of treatment responseThe role of growth arrest specific protein 6 in antiphospholipid syndrome

赵亚云

Effect of rituximab treatment for renal involvement in Sjögren's syndrome

陈辰

Unsupervised machine learning improves clinical stratification and prognostic evaluation for antiphospholipid syndrome: A large cohort study from China

莫万星

The Role of Peripheral B-Cell Subsets in Idiopathic Inflammatory Myopathies: Implications for Pathogenesis and Therapeutic Targets

唐蕴荻

Soluble receptor LILRA3 as a novel regulator of thrombosis by inducing neutrophil-mediated NETosis in antiphospholipid syndrome (APS)

赵亮

Risk Factors and Prognostic Outcomes of Patients with Idiopathic Inflammatory Myopathy complicated with infection

王平

MDSCs are important osteoclast precursors primed by B cells in rheumatoid arthritis

李雪

Low-dose IL-2 Therapy for Neuromyelitis Optica
Spectrum Disorder with Anxiety State and Insomnia: A Case Report

李浩

Impact of long COVID on patients with Sjögren’s syndrome and risk factors: a longitudinal study in China

韩奕芃

Immune profiling of T helper cell subsets in SSA/SSB double negative Sjögren’s syndrome patients in China

魏超楠

Combination of scavenger receptor-A with anti-cyclic citrullinated peptide antibody for the diagnosis of rheumatoid arthritis

程功

A disease typing study of Sjögren's syndrome based on machine learning

许曦

Serum IgG4 level is associated with disease activity of ANCA-associated vasculitis

邢晓燕

Treatment of Active Dermatomyositis by Tofacitinib: A Prospective Cohort Pilot Study

王文琼

The effect of dickopf-1 on bone erosion and synovitis in inflammatory arthritis

王文琼

The immune and growth characteristics of children born to mothers with systemic lupus erythematosus

刘庆红

Risk factors for vascular occlusion in patients with eosinophilic granulomatosis with polyangiitis

孙晓麟

Single-cell multi-omics analysis revealing immune features of inactivated COVID-19 vaccination in systemic lupus erythematosus patients

徐浩杰

A case on the efficacy of upadacitinib in treating Sjögren’s syndrome complicated with atopic dermatitis

苗苗

Impaired Skin-homing CLA+ Regulatory T cell: an Indicator of Disease Severity in Idiopathic Inflammatory Myopathies

梁人戈

Elevated Expression of Mer Receptor Tyrosine Kinase of NK cells in Patients with Systemic Lupus Erythematosus

裴文文

Axl Receptor Tyrosine Kinase Regulates Innate Immune in Diffuse Alveolar Hemorrhage in Murine Lupus

姚然然 

梁人戈

Coronavirus Disease 2019 and Psoriatic Arthritis: Features and Connections

饶佩诗

A novel P2X7 receptor antagonist EVT-401 inhibits inflammatory arthritis by regulating fibroblast-like synoviocyte

朱丹雪

Deficiency of circulating CLA+Tregs and the therapeutic potential in rheumatoid arthritis

宋子怡

Ruxolitinib in adult macrophage activation syndrome:A single-centre case series of eight patients

王一帆

Exploring the role of T follicular helper cells in immune-related adverse events and the therapeutic potential of low-dose IL-2

曹世雄

Serum sCD25 is an indicator for Rheumatoid Arthritis-Associated Interstitial Lung Disease